THNR
Amplify Weight Loss Drug & Treatment ETF
1W: -2.3%
1M: -0.5%
3M: -8.1%
YTD: -4.2%
1Y: +10.6%
$24.77
+0.24 (+0.98%)
Weekly Expected Move ±3.0%
$23
$24
$24
$25
$26
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
Key Statistics
AUM$3M
Holdings22
Top 10 Wt70.9%
Volume361
Avg Volume1,136
Beta0.41
Portfolio Fundamentals
P/E19.8
P/B5.0
Div Yield2.15%
ROE26.6%
% Profitable50%
Inception2024-05-21
Sector Allocation
Healthcare
97.6%
Other
1.5%
Financial Services
1.0%
Top 10 Holdings
| # | Name | Ticker | Weight % | Market Value | Shares |
|---|---|---|---|---|---|
| 1 | Novo Nordisk A/S | NVO | 14.69% | $602,562 | 13,608 |
| 2 | Eli Lilly & Co | LLY | 13.17% | $540,326 | 529 |
| 3 | Amgen Inc | AMGN | 6.04% | $247,732 | 749 |
| 4 | Arrowhead Pharmaceuticals Inc | ARWR | 5.86% | $240,543 | 3,287 |
| 5 | Regeneron Pharmaceuticals Inc | REGN | 5.66% | $232,234 | 369 |
| 6 | Chugai Pharmaceutical Co Ltd | 4519.T | 5.59% | $229,501 | 4,600 |
| 7 | Roche Holding AG | ROP.SW | 5.18% | $212,594 | 510 |
| 8 | Innovent Biologics Inc | 1801.HK | 4.98% | $204,260 | 20,000 |
| 9 | Merck & Co Inc | MRK | 4.91% | $201,405 | 1,763 |
| 10 | AstraZeneca PLC | AZN | 4.78% | $196,272 | 1,063 |